Robert K. Weigle

CIK: 0001897664

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)4 (66.7%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TNON

Tenon Medical, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

TNON
Tenon Medical, Inc.
Jul 31, 2026
Exercise(M)
Direct
10.7K shares-
TNON
Tenon Medical, Inc.
Jan 5, 2026
Tax Payment(F)
Direct
3.4K shares at avg. $0.93$3K
TNON
Tenon Medical, Inc.
Jan 1, 2026
Exercise(M)
Direct
10.7K shares-
TNON
Tenon Medical, Inc.
Oct 13, 2025
Award(A)
Restricted Stock Units
Direct
21.5K shares-
TNON
Tenon Medical, Inc.
May 22, 2025
Exercise(M)
Direct
78 shares-
TNON
Tenon Medical, Inc.
May 22, 2024
Exercise(M)
Direct
78 shares-

		Type	Shares	Price		Ownership
Jul 31, 2026	TNON Tenon Medical, Inc.	Exercise(M)	10,732	-	$0	Direct
Jan 5, 2026	TNON Tenon Medical, Inc.	Tax Payment(F)	3,413	$0.93	$3,174	Direct
Jan 1, 2026	TNON Tenon Medical, Inc.	Exercise(M)	10,732	-	$0	Direct
Oct 13, 2025	TNON Tenon Medical, Inc.	Award(A) Restricted Stock Units	21,464	-	-	Direct
May 22, 2025	TNON Tenon Medical, Inc.	Exercise(M)	78	-	-	Direct
May 22, 2024	TNON Tenon Medical, Inc.	Exercise(M)	78	-	-	Direct

1-6 of 6 transactions

About WEIGLE ROBERT K

WEIGLE ROBERT K (SEC CIK 0001897664) files insider reports with the SEC as Director of Tenon Medical, Inc. (TNON).

Signal8 holds 4 ownership filings by WEIGLE ROBERT K, all Form 4s, filed between Oct 15, 2025 and Aug 4, 2026. Those filings report 6 transactions, from May 22, 2024 to Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on WEIGLE ROBERT K's filings is in LOS GATOS, CA.

Recent filings by WEIGLE ROBERT K

Jul 31, 2026: Option exercise of TNON shares (Form 4, code M).
Jan 5, 2026: Tax withholding of TNON shares (Form 4, code F).
Jan 1, 2026: Option exercise of TNON shares (Form 4, code M).
Oct 13, 2025: Grant or award of TNON derivative securities (Form 4, code A).
May 22, 2025: Option exercise of TNON shares (Form 4, code M).

Other insiders filing for Tenon Medical, Inc. (TNON)

Batton Thomas Henry Jr, Chief Revenue Officer
HRT FINANCIAL LP, 10% Owner
Williamson Kevin, Chief Financial Officer
Jacques Kristine M, Director
HOWARD IVAN, Director
Hochschuler Stephen, Director

How to read Form 4 transaction codes